ADA deficiency approved for treatment of gene therapy why
Answers
Answered by
1
Answer:
We believe that early intervention with gene therapy in patients with SCID due to ADA deficiency can reduce the risk of thymic involution and that optimization of the conditioning procedure will improve engraftment and immune recovery.
Explanation:
please drop some thanks for me
Answered by
0
Explanation:
We believe that early intervention with gene therapy in patients with SCID due to ADA deficiency can reduce the risk of thymic involution and that optimization of the conditioning procedure will improve engraftment and immune recovery
Similar questions